A phase III Randomized Open-Label Multi-Center study of ruxolitinib vs. best available therapy in patients with corticosteroid-refractory chronic graft vs host disease after allogenic stem cell transplantation
Clinical Trial Grant
Awarded By
Incyte Corporation
Start Date
May 11, 2017
End Date
September 16, 2019
Awarded By
Incyte Corporation
Start Date
May 11, 2017
End Date
September 16, 2019